Thu, Mar 28, 2024 2:00 PM – 3:00 PM EDT

Presenters: Sonja Wustrack, MPH, Managing Director, Integrated Evidence Generation and Michelle Leavy, MPH Director, Real-World Evidence Strategy

Register >>

Integrated evidence generation is gaining traction in the biopharmaceutical industry as an approach to aligning evidence needs across functions within a company. Real-world data and real-world evidence play a key role in integrated evidence generation plans, as these data, which reflect real-world care settings, patient populations, and outcomes, are often of particular interest to decision-makers.

Embracing automated integrated evidence generation helps companies access robust, relevant data and develop comprehensive evidence on effectiveness, safety, and value to support decision-making by a range of stakeholders, from regulatory agencies to payers to clinicians.

Join Sonja Wustrack, MPH and Michelle Leavy, MPH as they explore:

  • The evolving role of registries in integrated evidence generation planning
  • Practical use cases for registries across the product lifecycle
  • Leveraging novel technologies to improve registry efficiency and reduce time to meaningful data

**Please be advised this webinar is intended for pharmaceutical and medical device companies. Due to the proprietary nature of the content, all registration approval is at the discretion of OM1. Vendors and consultants will not be permitted to attend at this time.